{
    "id": "dbpedia_1637_2",
    "rank": 12,
    "data": {
        "url": "http://npic.orst.edu/factsheets/archive/imidacloprid.html",
        "read_more_link": "",
        "language": "en",
        "title": "Imidacloprid Technical Fact Sheet",
        "top_image": "http://npic.orst.edu//images/npic-logo-horiz-hi.png",
        "meta_img": "",
        "images": [
            "http://npic.orst.edu//images/npic-logo-horiz-hi.png",
            "http://npic.orst.edu/images/youtwitface.png",
            "http://npic.orst.edu/images/fsimages/imidacloprid.jpg",
            "http://npic.orst.edu/images/fsimages/osulogo.gif"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "Inhalation LC50 Up to and including 0.05 mg/L\n\n(â‰¤0.05 mg/L) Greater than 0.05 through 0.5 mg/L\n\n(>0.05-0.5 mg/L) Greater than 0.5 through 2.0 mg/L\n\n(>0.5-2.0 mg/L) Greater than 2.0 mg/L\n\n(>2.0 mg/L) Primary Eye Irritation Corrosive (irreversible destruction of ocular tissue) or corneal involvement or irritation persisting for more than 21 days Corneal involvement or other eye irritation clearing in 8 - 21 days Corneal involvement or other eye irritation clearing in 7 days or less Minimal effects clearing in less than 24 hours"
    }
}